Shaoshui Chen

机构：Binzhou Medical University, Shandong University of Aeronautics · ORCID：0000-0002-7134-9475

发表论文 35 篇 · 总被引 1181 次 · h-index 15

代表论文

• AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon–Small-Cell Lung Cancer With EGFR Exon 19 Deletion or L858R Mutations (2022 · Journal of Clinical Oncology · 被引 294)
• Efficacy of Aumolertinib (HS-10296) in Patients With Advanced EGFR T790M+ NSCLC: Updated Post-National Medical Products Administration Approval Results From the APOLLO Registrational Trial (2021 · Journal of Thoracic Oncology · 被引 150)
• Microwave ablation plus chemotherapy versus chemotherapy in advanced non-small cell lung cancer: a multicenter, randomized, controlled, phase III clinical trial (2020 · European Radiology · 被引 75)
• Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer (2024 · JAMA Oncology · 被引 63)
• Thoracic Radiotherapy Improves the Survival in Patients With EGFR -Mutated Oligo-Organ Metastatic Non–Small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors: A Multicenter, Randomized, Controlled, Phase III Trial (2024 · Journal of Clinical Oncology · 被引 52)
• Knockdown of c-Myc activates Fas-mediated apoptosis and sensitizes A549 cells to radiation (2017 · Oncology Reports · 被引 43)